Abstract:Abstract Lipid nanoparticles for delivering mRNA therapeutics hold immense promise for the treatment of a wide range of lung-associated diseases. However, the lack of effective methodologies capable of identifying the pulmonary delivery profile of chemically distinct lipid libraries poses a significant obstacle to the advancement of mRNA therapeutics. Here we report the implementation of a barcoded high-throughput screening system as a means to identify the lung-targeting efficacy of cationic, degradable lipid-like materials. We combinatorially synthesize 180 cationic, degradable lipids which are initially screened in vitro. We then use barcoding technology to quantify how the selected 96 distinct lipid nanoparticles deliver DNA barcodes in vivo. The top-performing nanoparticle formulation delivering Cas9-based genetic editors exhibits therapeutic potential for antiangiogenic cancer therapy within a lung tumor model in female mice. These data demonstrate that employing high-throughput barcoding technology as a screening tool for identifying nanoparticles with lung tropism holds potential for the development of next-generation extrahepatic delivery platforms.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the effectiveness and specificity of pulmonary mRNA delivery. Specifically, the researchers developed a high - throughput barcode screening system to identify cationic, degradable lipid - like materials (CAD lipids) that can effectively deliver mRNA to the lungs. Through this method, they hope to overcome the challenge of low delivery efficiency of current mRNA delivery systems in non - liver tissues, especially in the application of pulmonary disease treatment. ### Research Background - **Potential of mRNA Therapy**: Lipid nanoparticles (LNPs) as mRNA delivery vectors show great potential in vaccination, protein replacement therapy, cancer immunotherapy, and CRISPR - Cas gene editing. - **Delivery Challenges**: Although significant progress has been made in mRNA therapy, how to efficiently deliver mRNA to non - liver tissues (such as the lungs) remains a major challenge. The lungs are an important target for mRNA delivery because of their rich pathological targets (endothelial cells, epithelial cells, and immune cells). ### Research Methods - **High - Throughput Barcode Technology**: The researchers designed a combinatorial library containing 180 different CAD lipids and evaluated the in vitro and in vivo delivery effects of these lipids through high - throughput screening technology. - **In Vivo Screening**: 96 CAD lipid nanoparticles with good performance were selected, co - encapsulated with DNA barcodes and mRNA, and injected into mice by systemic administration. Then, the accumulation of these nanoparticles in different organs was quantified by deep - sequencing technology. ### Main Findings - **Identification of Lung - Targeting Lipids**: Through high - throughput screening, the researchers identified 21 CAD lipid nanoparticles that can effectively deliver mRNA to the lungs. - **Best Candidate**: Further screening found that LNP - CAD9 has the best delivery effect in the lungs, and the mRNA it delivers is mainly expressed in the lungs (accounting for about 90% of the total fluorescence intensity). - **Gene - Editing Ability**: LNP - CAD9 can not only efficiently deliver mRNA, but also achieve efficient gene editing in lung endothelial cells, showing significant anti - angiogenic treatment potential. ### Application Prospects - **Antitumor Treatment**: The researchers used LNP - CAD9 to conduct anti - angiogenic treatment experiments in a lung tumor model. The results showed that LNP - CAD9 can significantly inhibit the expression of VEGFR2, thereby inhibiting tumor growth. - **Future Directions**: This study provides important tools and technical support for the development of a new generation of mRNA delivery platforms for non - liver tissues, and is expected to promote the application of mRNA therapy in more disease treatments. In conclusion, this paper successfully identified CAD lipid nanoparticles that can efficiently deliver mRNA to the lungs through high - throughput barcode technology, providing new possibilities for the treatment of lung diseases.

High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models

Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery

Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing

Branched‐Tail Lipid Nanoparticles for Intravenous mRNA Delivery to Lung Immune, Endothelial, and Alveolar Cells in Mice

Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments

Inhaled mRNA nanoparticles dual-targeting cancer cells and macrophages in the lung for effective transfection

Crown-like Biodegradable Lipids Enable Lung-Selective Mrna Delivery and Dual-Modal Tumor Imaging in Vivo.

High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing

Development of a high-throughput platform for screening lipid nanoparticles for mRNA delivery.

RNA encoded peptide barcodes enable efficient in vivo screening of RNA delivery systems

Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery

Ligand-free biodegradable poly(beta-amino ester) nanoparticles for targeted systemic delivery of mRNA to the lungs

Synthesis of ionizable lipopolymers using split-Ugi reaction for pulmonary delivery of various size RNAs and gene editing

Lung-specific supramolecular nanoparticles for efficient delivery of therapeutic proteins and genome editing nucleases

Discovery of a Peptoid-Based Nanoparticle Platform for Therapeutic mRNA Delivery via Diverse Library Clustering and Structural Parametrization

Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis

In Silico Screening Accelerates Nanocarrier Design for Efficient mRNA Delivery

Lung-Specific mRNA Delivery Enabled by Sulfonium Lipid Nanoparticles

Cationic Lipid Pairs Enhance Liver-to-Lung Tropism of Lipid Nanoparticles for In Vivo mRNA Delivery

Combinatorial development of nebulized mRNA delivery formulations for the lungs

Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing